Skip to Main Content

Author Details

Fei Yang
Oregon Health & Science University
2002
29
11
PMIDPaper TitleJournal TitlePublished Year
37170730Study of 43 SLE patients with autoimmune liver cirrhosis: emphasis on clinical features and differences from lupus without cirrhosis.Int J Rheum Dis2023
37088803NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia.Blood Cancer J2023
34482403Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.Blood2022
35802949A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemia.Cancer Genet2022
36568279A novel <i>BCL11A</i> polymorphism influences gene expression, therapeutic response and epilepsy risk: A multicenter study.Front Mol Neurosci2022
33769269Kimura's disease: clinical characteristics, management and outcome of 20 cases from China.Clin Exp Rheumatol2022
35258401Adult acute myeloid leukemia patients with <i>NUP98</i> rearrangement have frequent cryptic translocations and unfavorable outcome.Leuk Lymphoma2022
34874823Clinical characteristics of IgG4-related respiratory disease patients: a large Chinese cohort study.Clin Exp Rheumatol2022
32793960Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study.Rheumatology (Oxford)2021
33600452Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.PLoS One2021
33568210Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease.Arthritis Res Ther2021
34496019A novel activating JAK1 mutation in chronic eosinophilic leukemia.Blood Adv2021
34277657Diagnosis of <i>Mycobacterium tuberculosis</i> Septic Shock in Patients With Anti-synthetase Syndrome Based on Next-Generation Sequencing: A Case Report and Literature Review.Front Med (Lausanne)2021
34093952Primary renal NUT carcinoma identified by next-generation sequencing: a case report and literature review.Int J Clin Exp Pathol2021
34001958Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients.Sci Rep2021
33415580The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.Invest New Drugs2021
32463619Treatment Pathways Leading to Biologic Therapies for Ulcerative Colitis and Crohn's Disease in the United States.Clin Transl Gastroenterol2020
32097488Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.Rheumatology (Oxford)2020
31848884Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.Mol Diagn Ther2020
32386024Effect of deletion of SUMOylation on dendritic cell function in septic mice and its role in sepsis.Zhong Nan Da Xue Xue Bao Yi Xue Ban2020
32211343Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Encephalitis and Meningitis: A Large, Prospective Case Series of 213 Patients.Front Cell Infect Microbiol2020
31026597Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.J Mol Diagn2019
31124175Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.Am J Hematol2019
29959414Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS.Leukemia2018
27124934Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.Am J Clin Pathol2016
23666688Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.Methods Mol Biol2013
21908430The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.Blood2011
21860020TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.Blood2011
11774355Using mRNA expression profiling to determine anticancer drug efficacy.Cytometry2002
  • 1 - 29 of 29

Recommended Authors

Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 18
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 3
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 6
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 1
Institute of Pathology, Heidelberg University Hospital
Career Start Year 2010
Number of shared co-authors 2
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 2
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 4
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 0
Adelaide Medical School, University of Adelaide
Career Start Year 2003
Number of shared co-authors 4
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 3
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 2
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 3
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 3
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 1
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 2
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 5
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 5
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 1
The University of Chicago
Career Start Year 1994
Number of shared co-authors 7
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 4
Kyoto University
Career Start Year 1993
Number of shared co-authors 4
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 3
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 3

Collaborators

Oregon Health and Science University
Co-authored papers 12
Oregon Health and Science University
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
University of Utah Huntsman Cancer Institute
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 2
Oregon Health & Science University School of Medicine
Co-authored papers 2
Huntsman Cancer Institute, University of Utah
Co-authored papers 2
The University of Texas Southwestern Medical Center
Co-authored papers 1
Moores Cancer Center and Department of Medicine, University of California
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
University of Colorado Division of Hematology
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
The Ohio State University
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Washington University School of Medicine in St. Louis
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Association for Molecular Pathology
Co-authored papers 1
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 1